VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 167 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $13,876,364 | -12.1% | 1,559,142 | 0.0% | 23.22% | +23.7% |
Q1 2024 | $15,794,108 | +0.7% | 1,559,142 | 0.0% | 18.77% | +7.6% |
Q4 2023 | $15,684,969 | +7.4% | 1,559,142 | 0.0% | 17.45% | +0.2% |
Q3 2023 | $14,609,161 | -61.8% | 1,559,142 | 0.0% | 17.42% | -42.8% |
Q2 2023 | $38,245,753 | +5.4% | 1,559,142 | 0.0% | 30.44% | -5.0% |
Q1 2023 | $36,281,234 | -8.1% | 1,559,142 | 0.0% | 32.04% | +5.4% |
Q4 2022 | $39,461,884 | +31.1% | 1,559,142 | 0.0% | 30.41% | +27.8% |
Q3 2022 | $30,100,000 | -24.2% | 1,559,142 | 0.0% | 23.79% | -22.0% |
Q2 2022 | $39,700,000 | -1.0% | 1,559,142 | 0.0% | 30.52% | +41.5% |
Q1 2022 | $40,100,000 | +41.2% | 1,559,142 | +130.0% | 21.56% | +150.2% |
Q4 2021 | $28,400,000 | -3.7% | 677,777 | 0.0% | 8.62% | -0.2% |
Q3 2021 | $29,500,000 | -77.5% | 677,777 | -75.6% | 8.64% | -57.1% |
Q2 2021 | $131,000,000 | -8.0% | 2,777,777 | 0.0% | 20.13% | -13.6% |
Q1 2021 | $142,417,000 | +92.5% | 2,777,777 | 0.0% | 23.30% | +37.9% |
Q4 2020 | $74,000,000 | – | 2,777,777 | – | 16.90% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $39,700,000 | 30.52% |
SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $565,858,000 | 4.50% |
Zebra Capital Management LLC | 25,419 | $647,000 | 1.90% |
Alaska Permanent Fund Corp | 2,300,000 | $58,581,000 | 0.84% |
CLARK ESTATES INC/NY | 180,000 | $4,585,000 | 0.79% |
Temasek Holdings (Private) Ltd | 5,602,553 | $142,697,025 | 0.78% |
SECTOR GAMMA AS | 110,223 | $2,807,000 | 0.63% |
Avidity Partners Management LP | 758,211 | $19,312,000 | 0.44% |
New Vernon Capital Holdings II LLC | 14,501 | $369,000 | 0.30% |
DUALITY ADVISERS, LP | 116,415 | $2,965,000 | 0.29% |